CTOs on the Move


 
bioVIGIL headquartered in Las Vegas, Nevada, is a leading provider of healthcare infection control and disease mitigation solutions that enhance the patient care environment improving patient safety, healthcare quality, and hospital bottom lines.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Oppo Medical

Oppo Medical is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SAINT MARYS REGIONAL MEDICAL CENTER

SAINT MARYS REGIONAL MEDICAL CENTER is a Lewiston, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Harborchase-Sterling Heights

Harborchase-Sterling Heights is a Sterling Heights, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ShapeUp

ShapeUp is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Providence, RI. To find more information about ShapeUp, please visit www.shapeup.com

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.